Date: June 22, 2022
The U.S. Department of Health and Human Services (HHS) remains committed to distributing vaccines and therapeutics for free to communities across the country. While vaccines still remain the best way out of the pandemic, there are therapeutics, both pre-treatment and treatments, available that can help those at highest risk. It’s not only critical that health care providers are aware of and understand the eligibility criteria for prescribing these medications, but it’s also imperative that potential patients are armed with the right information that can help quickly connect them with these critical drugs.
Join the U.S. Surgeon general along with subject matter experts from the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) for a webinar and interactive discussion on the current COVID-19 therapeutics landscape and opportunities for increased outreach and education across providers and consumers. HHS encourages members from patient advocacy groups as well as clinicians to join this important call.
What: Discussion with the U.S. Surgeon General on COVID-19 Therapeutics
Date: Thursday, June 23, 2022
Time: 2:00 PM – 3:00 PM ET
Participants:
Dr. Vivek Murthy, U.S. Surgeon General
Dr. Meg Sullivan, ASPR Chief Medical Officer
Dr. Meghan Pennini, ASPR Therapeutics Director
Dr. Michael Anderson, ASPR Senior Advisor
Dr. Derek Eisnor, ASPR/BARDA Medical